Piraml.Phyto.

PIRAMALPHYTOCARE10 Dec 2019

Pharmaceuticals

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Piraml.Phyto.

Piraml.Phyto.

Pharmaceuticals

PIRAMALPHYTOCARE10 Dec 2019

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
03-Dec-2019	BC	Amalgamation	12-Dec-2019
05-Dec-2019	BC	Sub: Suspension of trading in equity shares -Piramal Phytocare Limited In pursuance of Regulation 3.1.2 of the National Stock Exchange (Capital Market) Trading Regulations Part A,it is hereby no	11-Dec-2019
05-Nov-2019	BC	Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform that Mr. Ankit Kotak, Chief Financial Officer ('CFO') of the Company has	05-Nov-2019
24-Oct-2019	BC	Piramal Phytocare Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2019 ,inter alia, to consider and approve Regulation 29 of the Securities and	04-Nov-2019
11-Jul-2019	BC	AGM 05/08/2019 Intimation Of Newspaper Advertisement Of Publication Of Notice Of The 18th Annual General Meeting (As Per BSE Announcement Dated 15.07.2019) Outcome of 18th Annual General Mee	05-Aug-2019

No Rights has been declared by PIRAMALPHYTOCARE

Book Closure

Record Date	Split Date	Purpose
12-Dec-2019	-	Amalgamation
11-Dec-2019	-	Sub: Suspension of trading in equity shares -Piramal Phytocare Limited In pursuance of Regulation 3.1.2 of the National Stock Exchange (Capital Market) Trading Regulations Part A,it is hereby no
05-Nov-2019	-	Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform that Mr. Ankit Kotak, Chief Financial Officer ('CFO') of the Company has
04-Nov-2019	-	Piramal Phytocare Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2019 ,inter alia, to consider and approve Regulation 29 of the Securities and
05-Aug-2019	-	AGM 05/08/2019 Intimation Of Newspaper Advertisement Of Publication Of Notice Of The 18th Annual General Meeting (As Per BSE Announcement Dated 15.07.2019) Outcome of 18th Annual General Mee

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Piramal Phytocare Ltd(Merged) ₹22.70(0.00/0.00%)	22.70	+0.00	58.93	-18.93	0.00	-1.86
Lupin Ltd ₹1,655.70(+0.95/0.06%)	1,655.70	+0.95	75,415.25	133.18	36.60	3.91
Ipca Laboratories Ltd ₹1,345.00(+7.30/0.55%)	1,345.00	+7.30	33,938.01	88.94	61.57	5.46
J B Chemicals & Pharmaceuticals Ltd ₹1,870.00(-19.90/-1.05%)	1,870.00	-19.90	29,330.27	80.31	57.90	10.92
Sanofi India Ltd ₹8,557.40(-66.85/-0.78%)	8,557.40	-66.85	19,861.65	59.17	33.61	19.54
IOL Chemicals & Pharmaceuticals Ltd ₹397.95(+2.40/0.61%)	397.95	+2.40	2,322.10	-0.40	13.44	1.46

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18
Gross Sales	7.12	3.87	4.78	7.24	6.18	6.92
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	7.12	3.87	4.78	7.24	6.18	6.92
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.01	0.00	0.00	0.00	0.00	0.05
Total Income	7.13	3.87	4.78	7.24	6.18	6.97
Total Expenditure	8.73	7.31	7.42	7.81	7.44	9.95
PBIDT	-1.60	-3.44	-2.64	-0.57	-1.26	-2.98
Interest	0.39	0.36	0.31	0.32	0.12	0.00
PBDT	-1.99	-3.80	-2.95	-0.89	-1.38	-2.98
Depreciation	0.03	0.04	0.01	0.01	0.01	0.01
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-2.02	-3.84	-2.96	-0.90	-1.39	-2.99
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-2.02	-3.84	-2.96	-0.90	-1.39	-2.99

EPS (Unit Curr.)	-0.80	-1.50	-1.10	-0.30	-0.50	-1.20
EPS (Adj) (Unit Curr.)	-0.80	-1.50	-1.10	-0.30	-0.50	-1.20
Calculated EPS (Unit Curr.)	-0.78	-1.48	-1.14	-0.35	-0.54	-1.15
Calculated EPS (Adj) (Unit Curr.)	-0.78	-1.48	-1.14	-0.35	-0.54	-1.15
Calculated EPS (Ann.) (Unit Curr.)	-3.11	-5.92	-4.56	-1.39	-2.14	-4.61
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-3.11	-5.92	-4.56	-1.39	-2.14	-4.61
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	25.96	25.96	25.96	25.96	25.96	25.96
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-22.47	-88.89	-55.23	-7.87	-20.39	-43.06
PBDTM(%)	-27.95	-98.19	-61.72	-12.29	-22.33	-43.06
PATM(%)	-28.37	-99.22	-61.92	-12.43	-22.49	-43.21

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 19	Mar 18	Mar 17	Mar 16	Mar 15	Mar 14
SOURCES OF FUNDS :
Share Capital	25.96	25.96	25.96	25.96	25.96	25.96
Reserves Total	-51.50	-43.39	-20.91	-20.97	-17.69	-14.23
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	-25.54	-17.43	5.05	4.99	8.27	11.73
Secured Loans	13.44	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Total Debt	13.44	0.00	0.00	0.00	0.00	0.00
Total Liabilities	-12.10	-17.43	5.05	4.99	8.27	11.73
APPLICATION OF FUNDS :
Gross Block	0.44	0.44	0.44	0.44	23.53	23.54
Less : Accumulated Depreciation	0.17	0.13	0.08	0.04	18.50	13.86
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.27	0.31	0.36	0.40	5.03	9.68
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.12	0.32	0.31	0.50	0.34	0.00
Sundry Debtors	0.64	1.00	1.24	1.47	1.83	1.43
Cash and Bank	1.07	1.98	2.88	3.20	0.95	0.90
Loans and Advances	5.53	4.17	0.42	0.17	0.14	0.08
Total Current Assets	7.36	7.47	4.85	5.33	3.26	2.41
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	19.33	24.02	0.43	1.13	0.46	0.91
Provisions	0.55	1.05	0.10	0.03	0.00	0.00
Total Current Liabilities	19.88	25.07	0.54	1.16	0.46	0.91
Net Current Assets	-12.52	-17.60	4.31	4.17	2.80	1.50
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	-12.25	-17.29	4.67	4.57	7.83	11.18
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Cash and Cash Equivalents at Beginning of the year	1.98	0.38	1.19	0.34	0.89
Net Cash from Operating Activities	-13.70	-0.95	-0.47	2.19	0.06
Net Cash Used In Investing Activities	0.00	2.55	-0.35	-1.34	-0.61
Net Cash Used In Financing Activities	12.78	0.00	0.00	0.00	0.00
Net Inc./Dec In Cash And Cash Equivalents	-0.92	1.60	-0.81	0.85	-0.55
Cash And Cash Equivalents At End Of The Year	1.06	1.98	0.38	1.19	0.34

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

56.08%

FII Shareholding

0.64%

DII Shareholding

3.37%

Public Shareholding

38.45%

**Promoter pledged shareholding 56.08%

About Piramal Phytocare Ltd(Merged)

Piramal Phytocare Ltd(Merged) is in the Pharmaceuticals sector, having a market capitalization of Rs. 58.54 crores. It has reported a sales of Rs. 7.12 crores and a net profit of Rs. -2.02 crores for the quarter ended December 2018. The company management includes , Gautam Doshi,Rajesh Laddha,N L Bhatia,Maneesh Sharma,Rashida Najmi (Piramal Phytocare Ltd(Merged)) among others.

Chairman

Registered office

Piramal Tower,Ganpatrao Kadam Marg Lower Par,Mumbai,Maharashtra,400013

FAX :91-22-30467855

Background

Incorporation Year2001

Face Value₹10

Market Lot1

How to buy Piraml.Phyto. shares on nse?

To buy Piraml.Phyto. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Piraml.Phyto. share price today?

The Piraml.Phyto. shares price on nse is Rs.22.7 today.

What is the market cap of Piraml.Phyto. shares on NSE ?

The company has a market capitalization of Rs.58.93Cr

What is the PE & PB ratio of Piraml.Phyto. shares ?

PE is 0 and PB is -1.86

What is the 52 Week High and Low of Piraml.Phyto. shares?

Piraml.Phyto. stock price high: Rs.24 Piraml.Phyto. stock price low: Rs.0